Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Eur J Endocrinol. 2020 Apr;182(4):413–421. doi: 10.1530/EJE-19-0905

Figure 2.

Figure 2.

Reductions in conventional and 11-oxygenated androgens in CRPC patients with AAP treatment. Symbols show individual patient data from baseline (BL) and after at least 4 weeks of AAP therapy. The dotted lines indicate LLOQ for each steroid, and values <LLOQ are plotted midway between 0 and LLOQ. Conversion factors from nmol/L to ng/dL: multiply value by 28.64 for A4, 28.84 for T, 30.24 for 11OHA4 and 11KT, 30.04 for 11KA4, and 30.44 for 11OHT.